Literature DB >> 6778498

Platelet-activating factor (PAF-acether) secretion from platelets: effect of aggregating agents.

M Chignard, J P Le Couedic, B B Vargaftig, J Benveniste.   

Abstract

Platelet-activating factor is a 1.0-alkyl-2 acetyl analogue of phosphatidylcholine (PAF-acether) which triggers platelet aggregation independently from ADP release and thromboxane A2 (TxA2) formation. PAF-acether was described initially as being secreted by rabbit basophils during an immunological challenge. We have now found that it is also formed by washed rabbit platelets stimulated by the calcium ionophore A23187, thrombin and collagen. These three agents are known to trigger platelet aggregation independently from the release of ADP and from the formation of TxA2. By contrast, ADP and arachidonic acid, the precursor of TxA2, which do not share these properties, and PAF-acether itself, were unable to induce PAF-acether formation. Our results suggest that PAF-acether may be the mediator responsible for ADP and TxA2 independent-aggregation.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6778498     DOI: 10.1111/j.1365-2141.1980.tb05993.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  31 in total

1.  Selective inhibition of adrenaline-induced human platelet aggregation by the structurally related Paf antagonist Ro 19-3704.

Authors:  M Schattner; A Parini; F Fouque; B B Vargaftig; L Touqui
Journal:  Br J Pharmacol       Date:  1989-04       Impact factor: 8.739

2.  Human platelets stimulated by thrombin produce platelet-activating factor (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) when the degrading enzyme acetyl hydrolase is blocked.

Authors:  L Touqui; M Hatmi; B B Vargaftig
Journal:  Biochem J       Date:  1985-08-01       Impact factor: 3.857

3.  Cardiac release of chemoattractants after ischaemia induced by coronary balloon angioplasty.

Authors:  F J Neumann; G Richardt; M Schneider; I Ott; H M Haupt; H Tillmanns; A Schömig; B Rauch
Journal:  Br Heart J       Date:  1993-07

4.  Role of platelet-activating factor (PAF) in platelet accumulation in rabbit skin: effect of the novel long-acting PAF antagonist, UK-74,505.

Authors:  F Pons; A G Rossi; K E Norman; T J Williams; S Nourshargh
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

5.  Mechanism of action of platelet activating factor in the pulmonary circulation: an investigation using a novel isotopic system in rabbit isolated lung.

Authors:  J P Seale; S Nourshargh; P G Hellewell; T J Williams
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

6.  Acute lung inflammation induced in the rabbit by local instillation of 1-0-octadecyl-2-acetyl-sn-glyceryl-3-phosphorylcholine or of native platelet-activating factor.

Authors:  G Camussi; I Pawlowski; C Tetta; C Roffinello; M Alberton; J Brentjens; G Andres
Journal:  Am J Pathol       Date:  1983-07       Impact factor: 4.307

7.  Dissociation between inhibition of phospholipid methylation and production of PAF-acether by rabbit platelets.

Authors:  L Touqui; M Chignard; C Jacquemin; F Wal; B B Vargaftig
Journal:  Experientia       Date:  1984-04-15

8.  Release of platelet-activating factor (PAF-acether) and 2-lyso PAF-acether from three cell types.

Authors:  J Benveniste; R Roubin; M Chignard; E Jouvin-Marche; J P Le Couedic
Journal:  Agents Actions       Date:  1982-12

9.  1-O-alkyl-linked phosphoglycerides of human platelets: distribution of arachidonate and other acyl residues in the ether-linked and diacyl species.

Authors:  H W Mueller; A D Purdon; J B Smith; R L Wykle
Journal:  Lipids       Date:  1983-11       Impact factor: 1.880

10.  Metabolism of platelet-activating factor by blood platelets and plasma.

Authors:  I Alam; J B Smith; M J Silver
Journal:  Lipids       Date:  1983-08       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.